TP53 and cancer: Ries et al., showed that by inducing mouse double minute 2 homolog (Mdm2) in mouse embryo fibroblasts, oncogenic Ras degrades p53 [12], indicating that Ras activation decreases p53 expression, leading to cancer cell survival.